Guangcheng Jiang;Frédérique Menzaghi;Roberta Vezza Alexander;Derek T. Chalmers;Zhiyong Luo;Javier Sueiras-Diaz;Claudio D. Schteingart;Robert H. Spencer
发明人:
Claudio D. Schteingart,Frédérique Menzaghi,Guangcheng Jiang,Roberta Vezza Alexander,Javier Sueiras-Diaz,Robert H. Spencer,Derek T. Chalmers,Zhiyong Luo
申请号:
US13543022
公开号:
US20130012448A1
申请日:
2012.07.06
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure of formula I:Pharmaceutical compositions containing these compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia. Inflammation associated with conditions such as IBD and IBS, ocular and otic inflammation, other disorders and conditions such as pruritis, edema, hyponatremia, hypokalemia, ileus, tussis and glaucoma are treatable or preventable with the pharmaceutical compositions of the invention.